Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, MSC-7234, Rockville, MD 20852, USA.
Cancer Causes Control. 2012 Dec;23(12):1881-91. doi: 10.1007/s10552-012-0024-9. Epub 2012 Sep 28.
To evaluate the association of body size-captured via whole-body dual-energy X-ray absorptiometry (DXA) and physical measurement-with serum sex steroid hormones and sex hormone binding globulin (SHBG), we utilized cross-sectional data and serum samples from the National Health and Nutrition Examination Survey (NHANES; 1999-2004).
Testosterone, androstanediol glucuronide (3-alpha-diol-G), estradiol, and SHBG were measured via immunoassay in serum samples from a total of 898 adult men (ages 20-90) participating in the morning examination. As part of the NHANES data collection, DXA scans and measurements of weight, height, and waist circumference were performed by trained staff. Linear regression was used to estimate associations between body size and hormone levels adjusted for potential confounders and NHANES sampling procedures.
Total bone area (cm(2)) was inversely associated with total testosterone (ng/mL) [beta = -0.12; p value < 0.01], while bone mineral density (g/cm(2)) was inversely associated with SHBG (nmol/L) [beta = -17.16; p value = 0.01]. Increased percent body fat was associated with lower concentrations of total testosterone [beta = -0.16; p value < 0.01] and SHBG [beta = -1.11; p value < 0.01] and higher concentrations of free estradiol (fg/mL) [beta = 12.52; p value < 0.01].
Clinical measures of body fat (measured via DXA scan) and anthropometric measures of body fat (BMI and waist circumference) provided similar inferences regarding the association between increased body fat and hormone levels in men. Increased body fat was associated with lower circulating levels of testosterone (total and free) and SHBG and higher circulating levels of free estradiol in men, while decreased bone mineral density was associated with higher circulating levels of SHBG.
通过全身双能 X 射线吸收法(DXA)和物理测量来评估体型与血清性激素和性激素结合球蛋白(SHBG)的关系,我们利用了来自国家健康和营养检查调查(NHANES;1999-2004 年)的横断面数据和血清样本。
在参加晨检的 898 名成年男性(年龄 20-90 岁)的血清样本中,通过免疫测定法测量了睾酮、雄烷二醇葡萄糖醛酸(3-α-二醇-G)、雌二醇和 SHBG。作为 NHANES 数据收集的一部分,由经过培训的工作人员进行了 DXA 扫描和体重、身高和腰围的测量。使用线性回归来估计体型与激素水平之间的关联,调整了潜在混杂因素和 NHANES 采样程序的影响。
总骨面积(cm(2))与总睾酮(ng/mL)呈负相关[β=-0.12;p 值<0.01],而骨密度(g/cm(2))与 SHBG(nmol/L)呈负相关[β=-17.16;p 值=0.01]。体脂肪百分比增加与总睾酮[β=-0.16;p 值<0.01]和 SHBG [β=-1.11;p 值<0.01]浓度降低以及游离雌二醇(fg/mL)[β=12.52;p 值<0.01]浓度升高有关。
身体脂肪的临床测量(通过 DXA 扫描测量)和身体脂肪的人体测量学测量(BMI 和腰围)在男性中提供了关于体脂肪增加与激素水平之间关联的相似推断。体脂肪增加与循环中睾酮(总睾酮和游离睾酮)和 SHBG 水平降低以及游离雌二醇水平升高有关,而骨密度降低与循环中 SHBG 水平升高有关。